Integrated OMICS and IT Supportive Strategies for Biomarker-Driven Drug Development and Application in Personalized and Precision Healthcare Services
Drug development continues to move in the direction of the development of clinical practice as applicable to Personalized and Precision Medicine (PPM), - where ideally the most effective therapy or treatment is determined by the genetic makeup of the patient. The area of PPM as an upgraded model of the healthcare servi...